DUNWILL

DUNWILL Medical Group's first subsidiary was established in 2006. The headquarters is located in Songjiang, Shanghai, at the Lingang Science and Technology Oasis, with a research and development subsidiary in San Diego, USA. It is a high-tech enterprise that focuses on cancer and metabolic disease diagnosis and treatment services, integrating product research and development, production, medical testing, and sales.In Shanghai, we own a research and development and production base with a Class III medical device manufacturing license, over 50 registered medical device products, and an independent medical laboratory accredited to international CAP standards. In San Diego, USA, we have a molecular diagnostics R&D laboratory. We hold multiple national invention patents and software copyrights. Our team includes domestic and international experts in clinical oncology, molecular biology, cell biology, bioinformatics, laboratory animal science, pathology, proteomics, biochemistry, and systems biology. Under the innovative "Medical-Research-Production-Treatment" cooperation model, after more than a decade of efforts, we have successfully built seven major medical diagnostic testing technology platforms related to cancer diagnosis and treatment as well as metabolic diseases. These projects cover all stages of treatment, including early diagnosis of cancer and metabolic diseases, efficacy monitoring, recurrence warning, and drug companion diagnostics.